脉络洞察 | medomino

In Pictures: Pharma Companies Are Quietly Using AI to Upgrade HCP Profiling

2025-07-08

Abstract:

Five MeDomino cases show how AI and HCP profiling support meeting invitations, new launches, KOL engagement, and precision outreach.

In 2025, pharma competition is moving fast. Who has not yet arranged AI + HCP profiling? These five MeDomino cases cover everything from meeting invitations to new product launches, showing how precision engagement can become much more creative.


1. AI-powered precision targeting improves meeting invitation communication efficiency by 60%

Pixel-level HCP profiles enabled precise invitations for a national conference.


2. A global top 20 pharma company worked with MeDomino for five years, with data growing beyond 30,000 records

Data flowed directly into the business, and 70% of sales reps actively followed HCP profiles. This is long-termism that wins.


3. A new product launch started from zero data, and AI found early adopters

No customer data for a new launch? MeDomino's database of four million physicians helps maximize launch precision.


4. Precisely connect with leading KOLs around launch

Precise targeting, academic influence, value penetration, and mindset change complete the academic promotion loop.


5. Break through the existing market with three-dimensional insight

How can an established drug better understand physicians? With AI, HCP insight becomes much easier to handle.


All cases have been desensitized, and solutions can be customized. Click the website button to apply for a product demo or trial.

More Cases

Learn More
演示
企微

扫描添加企业微信

企微二维码
邮箱

合作邮箱请发送至

service@medomino.com